Kiniksa director exercises RSUs, gets new awards

Kiniksa Pharmaceuticals International, plc director Richard S. Levy reported routine equity compensation activity.

Rhea-AI Filing Summary

Kiniksa Pharmaceuticals International, plc director Richard S. Levy reported routine equity compensation activity. He exercised 2,799 Restricted Share Units, receiving the same number of Class A Ordinary Shares, bringing his direct holdings in that class to 21,956 shares.

On the same date, he received new grants of 2,026 Restricted Share Units and a share option covering 12,158 Class A Ordinary Shares at an exercise price of $48.38 per share. Footnotes state the option vests in twelve substantially equal monthly installments over roughly one year, while the new RSUs vest in full on the earlier of the grant anniversary or the company’s next annual shareholder meeting.

Insider Trade Summary

2,799 shares exercised/converted

Exercise 4 txns

Insider Levy Richard S

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Share Option	12,158	$0.00	$0.00
Grant/Award	Restricted Share Units	2,026	$0.00	$0.00
Exercise	Restricted Share Units	2,799	$0.00	$0.00
Exercise	Class A Ordinary Share	2,799	$0.00	$0.00

Holdings After Transaction: Share Option — 12,158 contracts (Direct); Restricted Share Units — 2,026 contracts (Direct); Class A Ordinary Share — 21,956 shares (Direct)

Footnotes (4)

1. F1. Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.
2. F2. The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant with the final installment vesting on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026.
3. F3. The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026.
4. F4. The RSUs vested in a single installment on May 29, 2026; there was no expiration date for the RSUs.

Key Figures

RSUs exercised: 2,799 shares Shares held after exercise: 21,956 shares New RSU grant: 2,026 RSUs +3 more

6 metrics

RSUs exercised 2,799 shares Restricted Share Units converted to Class A Ordinary Shares on May 29, 2026

Shares held after exercise 21,956 shares Class A Ordinary Shares directly owned after RSU exercise

New RSU grant 2,026 RSUs Restricted Share Units granted on May 29, 2026

New option grant 12,158 options Share options over Class A Ordinary Shares granted May 29, 2026

Option exercise price $48.38 per share Conversion or exercise price for new share option

Option expiration May 28, 2036 Expiration date of new share option grant

Key Terms

Restricted Share Unit, Share Option, vests in their entirety, annual meeting of shareholders, +1 more

5 terms

Restricted Share Unit financial

"Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer."

A restricted share unit (RSU) is a promise by a company to give an employee a set number of company shares at a future date, typically after meeting time or performance conditions. For investors, RSUs matter because when they convert into actual shares they increase the number of shares outstanding (like unlocking more tickets in a game), which can dilute existing holders, and they align employee incentives with company performance, influencing behavior and long-term value.

Share Option financial

"The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant."

vests in their entirety financial

"The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year."

annual meeting of shareholders financial

"the date of the Issuer's annual meeting of shareholders in the following year."

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

Exercise or conversion of derivative security financial

"transaction_code_description: Exercise or conversion of derivative security"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Kiniksa (KNSA) director Richard S. Levy report?

Richard S. Levy exercised 2,799 Restricted Share Units into 2,799 Class A Ordinary Shares and received new grants of 2,026 RSUs plus an option for 12,158 Class A Ordinary Shares at $48.38 per share.

Did Kiniksa (KNSA) director Richard S. Levy buy or sell shares on the open market?

He did not report any open-market buys or sells. The Form 4 shows an exercise of previously granted RSUs into shares and new equity awards (RSUs and options) as part of compensation, with no market transactions disclosed.

How many Kiniksa Class A shares does Richard S. Levy hold after these transactions?

After exercising 2,799 Restricted Share Units, Richard S. Levy directly holds 21,956 Class A Ordinary Shares. This figure reflects his position in that class of stock following the reported Form 4 transactions on May 29, 2026.

What stock options were granted to Kiniksa (KNSA) director Richard S. Levy?

He received a share option for 12,158 Class A Ordinary Shares with an exercise price of $48.38 per share. The option vests in twelve substantially equal monthly installments beginning from the May 29, 2026 grant date.

What are the vesting terms of the new Kiniksa (KNSA) RSU grant to Richard S. Levy?

The new grant of 2,026 Restricted Share Units vests in full on the earlier of the one-year anniversary of the May 29, 2026 grant date or the date of Kiniksa’s annual meeting of shareholders in the following year.

What happened to the previously outstanding Kiniksa (KNSA) RSUs held by Richard S. Levy?

Previously granted RSUs representing 2,799 shares vested in a single installment on May 29, 2026. Upon vesting, they were settled into 2,799 Class A Ordinary Shares, and there was no expiration date for those RSUs before vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/02/2026 - 04:44 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Levy Richard S

(Last) (First) (Middle)

C/O KINIKSA PHARMACEUTICALS INT'L

105 PICCADILLY, SECOND FLOOR

(Street)

LONDON W1J 7NJ

(City) (State) (Zip)

UNITED KINGDOM

(Country)

2. Issuer Name and Ticker or Trading Symbol
Kiniksa Pharmaceuticals International, plc [ KNSA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Ordinary Share	05/29/2026		M		2,799	A	(1)	21,956	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Share Option	$48.38	05/29/2026		A		12,158		(2)	05/28/2036	Class A Ordinary Shares	12,158	$0	12,158	D
Restricted Share Units	(1)	05/29/2026		A		2,026		(3)	(3)	Class A Ordinary Shares	2,026	$0	2,026	D
Restricted Share Units	(1)	05/29/2026		M			2,799	(4)	(4)	Class A Ordinary Shares	2,799	$0	0	D

Explanation of Responses:

1. Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.

2. The option vests and becomes exercisable in twelve substantially equal monthly installments following the date of the grant with the final installment vesting on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026.

3. The RSUs vest in their entirety on the earlier of a) the anniversary of the date of the grant and b) the date of the Issuer's annual meeting of shareholders in the following year. The date of the grant is May 29, 2026.

4. The RSUs vested in a single installment on May 29, 2026; there was no expiration date for the RSUs.

	/s/ Douglas Barry, Attorney-in-Fact	06/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)